Digital twin-guided AI models increased the predictive risk for the primary composite endpoint by 2.72 times in patients compared to traditional methods, with a 5-year primary composite endpoint rate of 31.2% in the cohort.
Cohort (n=343)
No
Does incorporating digital twin-derived features into prognostic AI models improve performance and interpretability for predicting cardiovascular death risk in heart failure patients compared to using only clinical variables?
Digital twins derived from mechanistic computational models can capture patient-specific cardiovascular physiology and improve the performance and interpretability of AI prognostic models for heart failure.
Effect estimate: HR 2.72 (95% CI 1.53-5.06)
p-value: p=0.001
Heart failure (HF) is a highly heterogeneous condition, and current methods struggle to synthesize extensive clinical data for personalized care. Using data from 343 HF patients, we developed mechanistic computational models of the cardiovascular system to create digital twins. These twins, consisting of optimized measurable and unmeasurable parameters alongside simulations of cardiovascular function, provided comprehensive representations of individual disease states. Unsupervised machine learning applied to digital twin-derived features identified interpretable phenogroups and mechanistic drivers of cardiovascular death risk. Incorporating these features into prognostic AI models improved performance, transferability, and interpretability compared to models using only clinical variables. This framework demonstrates potential to enhance prognosis and guide therapy, paving the way for more precise, individualized HF management.
Gu et al. (Mon,) conducted a cohort in Heart Failure (n=343). Digital Twin Framework vs. Traditional risk assessment based on clinical variables was evaluated on Composite endpoint including all-cause mortality, LVAD implantation, and heart transplantation (HR 2.72, 95% CI 1.53-5.06, p=0.001). Digital twin-guided AI models increased the predictive risk for the primary composite endpoint by 2.72 times in patients compared to traditional methods, with a 5-year primary composite endpoint rate of 31.2% in the cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: